Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Clinical trial NCT00085254 · COMPLETED
Trial details
- NCT number
- NCT00085254
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2012-11-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.